Follow the people · Insider
Harpreet S. Dhaliwal
Harpreet S. Dhaliwal files insider transactions with the SEC as a chief technical ops officer of Vaxcyte (PCVX). We hold 2 disclosed purchases and sales filed since 1 February 2022, 1 of them in the last 90 days.
- Files forPCVX
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 November 2021 — 2 September 2026Chief Technical Ops Officer · Vaxcyte (PCVX)28 Form 4 lines · source: SEC Form 4
Everything they disclosed
28 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 361 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- had shares withheld for tax on 659 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 17,000 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 5 August 2026 · filed 5 August 2026
- ▼ sold on the open market 17,000 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 5 August 2026 · filed 5 August 2026
- exercised options over 17,000 shares of Vaxcyte (a derivative holding)SEC Form 45 August 2026Stock Option (right to buy) · traded 5 August 2026 · filed 5 August 2026
- had shares withheld for tax on 604 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- had shares withheld for tax on 604 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- was granted 53,409 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 292 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 465 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 46,424 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 46,424 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 53,409 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 292 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 465 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- ▼ sold on the open market 9,743 shares of VaxcyteSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- ▼ sold on the open market 9,743 shares of VaxcyteSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- had shares withheld for tax on 1,204 shares of VaxcyteSEC Form 410 September 2025Common Stock · traded 8 September 2025 · filed 10 September 2025
- had shares withheld for tax on 291 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 783 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 464 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- was granted 15,000 shares of Vaxcyte (a derivative holding)SEC Form 44 January 2023Stock Option (right to buy) · traded 30 December 2022 · filed 4 January 2023
- returned to the issuer 3,990 shares of Vaxcyte (a derivative holding)SEC Form 430 December 2022Stock Option (Right to Buy) · traded 28 December 2022 · filed 30 December 2022
- exercised options over 3,990 shares of VaxcyteSEC Form 430 December 2022Common Stock · traded 28 December 2022 · filed 30 December 2022
- had shares withheld for tax on 1,513 shares of VaxcyteSEC Form 47 September 2022Common Stock · traded 2 September 2022 · filed 7 September 2022
- was granted 45,000 shares of Vaxcyte (a derivative holding)SEC Form 44 March 2022Stock Option (right to buy) · traded 2 March 2022 · filed 4 March 2022
- was granted 17,500 shares of VaxcyteSEC Form 44 March 2022Common Stock · traded 2 March 2022 · filed 4 March 2022
- was granted 100,000 shares of Vaxcyte (a derivative holding)SEC Form 41 February 2022Stock Option (Right to Buy) · traded 8 November 2021 · filed 1 February 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.